Pharma firm Hepalink soars on trading debut

0 CommentsPrint E-mail China Daily, May 7, 2010
Adjust font size:

Shares of drugmaker Shenzhen Hepalink Pharmaceutical Co Ltd soared on the company's trading debut on Thursday against the backdrop of the sharp plunge of the overall market as analysts said it may boost investor interest in the pharmaceutical sector.

The price of Hepalink, the world's largest maker of the blood-thinner heparin, surged 18.36 percent to close at 175.17 yuan ($25.66). It climbed to the intraday high of 188 yuan from its initial public offering (IPO) price of 148 yuan, the highest on record for a Chinese stock.

Analysts said the strong performance of Hepalink indicated investors might turn to pharma shares, seen as a defensive investment in the short term amid the depressed market.

"The surge showed investors are still optimistic about the pharmaceutical sector given its defensive nature and the more favorable government policies to be rolled out soon," said Sun Weina, an analyst at Hongyuan Securities.

Sun noted that, in the short term, the stock does not face the risk of falling below the IPO price, but she warned of the high valuation as it may rekindle IPO fever despite regulators' warnings about overpriced offerings in the domestic stock market.

Hepalink raised 5.9 billion yuan through issuing 40.1 million shares in the most expensive IPO, which was priced at 73 times its 2009 earnings.

The high IPO price made the company's founders, the low-profile couple Li Li and Li Tan, who hold a combined stake of 72 percent, the wealthiest people in China overnight.

Based on the current stock price, the value of the stake exceeded 50 billion yuan ($7.3 billion), surpassing Wang Chuanfu, chairman of electric car manufacturer BYD, China's richest person in 2009 with a fortune of $5.1 billion, according to the 2009 Hurun China Rich List.

US investment bank Goldman Sachs, which paid $4.9 million for 12.5 percent of Hepalink in 2007, also saw a more than 200-fold return based on the current price.

The Shenzhen-based drug company was founded in 1998. It primarily produces herapin, which is purified from pig intestines then made into a shot used to prevent blood clots in patients with heart conditions or undergoing surgery.

As the only Chinese company accredited by the US Food and Drug Administration to export herapin, the company's net profit jumped from 161 million yuan in 2008 to 809 million yuan last year.

It said it would use the funds raised in the IPO to expand production capacity by building a 864 million yuan herapin sodium plant with annual capacity of 5 trillion units.

Print E-mail Bookmark and Share

Go to Forum >>0 Comments

No comments.

Add your comments...

  • User Name Required
  • Your Comment
  • Racist, abusive and off-topic comments may be removed by the moderator.
Send your storiesGet more from China.org.cnMobileRSSNewsletter
主站蜘蛛池模板: 国产成人黄色小说| 在线免费观看国产视频| 九九综合九九综合| 波多野吉衣一区二区| 别揉我的胸~啊~嗯~的视频| 里漫社扶她全彩口工漫画| 国产激情电影综合在线看| 92国产精品午夜福利| 奇米色在线视频| 东京热加勒比无码少妇| 无翼乌邪恶帝日本全彩网站| 久久精品国产一区二区三区肥胖| 欧美任你躁免费精品一区| 亚洲熟女精品中文字幕| 狠狠综合久久综合网站| 全免费毛片在线播放| 绿巨人app黄| 四虎精品久久久久影院| 视频精品一区二区三区| 国产成人精品999在线观看| 18禁止看的免费污网站| 国产麻豆精品高清在线播放| sqy2wc厕所撒尿| 尤物国午夜精品福利网站| 久久久久久夜精品精品免费啦| 日本黄色激情片| 亚洲jjzzjjzz在线播放| 欧美白人最猛性xxxxx| 人人爽人人爽人人片a免费| 精品无人区一区二区三区a| 国产在线无码视频一区二区三区| 亚洲人xxx日本人18| 国产精品资源一区二区| 99久久婷婷国产综合精品| 成人在线视频免费| 久久久无码精品亚洲日韩按摩 | 男爵夫人的调教| 午夜国产羞羞视频免费网站| 色在线亚洲视频www| 国产亚洲人成网站在线观看| 黑人巨茎美女高潮视频|